Mapping Alzheimer’s disease progression in 1309 MRI scans: Power estimates for different inter-scan intervals

Neuroimaging centers and pharmaceutical companies are working together to evaluate treatments that might slow the progression of Alzheimer’s disease (AD), a common but devastating late-life neuropathology. Recently, automated brain mapping methods, such as tensor-based morphometry (TBM) of structura...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hua, Xue, Lee, Suh, Hibar, Derrek P., Yanovsky, Igor, Leow, Alex D., Toga, Arthur W., Jack, Clifford R., Bernstein, Matt A., Reiman, Eric M., Harvey, Danielle J., Kornak, John, Schuff, Norbert, Alexander, Gene E., Weiner, Michael W., Thompson, Paul M.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2846999/
https://ncbi.nlm.nih.gov/pubmed/20139010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuroimage.2010.01.104
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados